RLMD Stock Analysis: Buy, Sell, or Hold?
RLMD - Relmada Therapeutics, Inc. Common Stock
$6.33
0.05 (0.80%)
▲
5d:
-5.38%
30d:
+0.0%
90d:
-9.44%
HOLD
MODERATE Confidence
Analysis Updated: Jul 6, 2026 12:00 AM ET
Earnings: Aug 06, 2026
29d
Get Alerted When RLMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: RLMD shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: RLMD shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: RLMD is currently trading at $6.33, which is considered slightly low relative to its 30-day fair value range of $6.23 to $6.98.
Technical Outlook: Technically, RLMD is in a uptrend. The price is currently testing key support at $6.26. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: RLMD has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $12.67 (+100.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, RLMD is in a uptrend. The price is currently testing key support at $6.26. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: RLMD has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $12.67 (+100.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$6.23 -
$6.98
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 100.1% below Wall St target ($12.67)
- CAUTION: 5-day price weakness (-5.4%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$6.23 -
$6.98
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$6.26
Resistance Level
$7.12
Current Trend
Uptrend
Technical data as of
Jul 6, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-15.44
Wall Street Target
$12.67
(+100.1%)
Share & Embed Analysis
Last updated: July 06, 2026 10:44 PM ET
Data refreshes hourly during market hours. Next update: 11:44 PM
Data refreshes hourly during market hours. Next update: 11:44 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RLMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 55 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 62 BUY |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 62 BUY |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$111 | 59 HOLD |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 57 HOLD |
